Venus Remedies (BOM:526953) Total Equity: ₹6,638 Mil (As of Mar. 2026)


BOM:526953 Venus Remedies Ltd BOM:526953
53 GF Score
Price ₹1,703.85
GF Value ₹468.24
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Venus Remedies Total Equity?

Venus Remedies BOM:526953 -1.81% 53 Total Equity is ₹6,638 Mil as of Mar. 2026. GuruFocus rates BOM:526953 with a GF Score™ of 53/100 and a GF Value™ of ₹468.24 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Venus Remedies's total equity for the quarter that ended in Mar. 2026 was ₹6,638 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Venus Remedies Total Equity Historical Data

* Premium members only.

The historical data trend for Venus Remedies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Venus Remedies Total Equity Chart

Venus Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,404.46 4,603.36 4,875.50 5,609.50 6,637.50

Venus Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,609.50 0.00 5,943.10 0.00 6,637.50
BOM:526953
53GF Score
Venus Remedies Ltd BOM:526953
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Venus Remedies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Venus Remedies's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=8537-1899.5
=6,638

Venus Remedies's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=8537-1899.5
=6,638

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹6,638 Mil mean?
Venus Remedies (BOM:526953) has a Total Equity of ₹6,638 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Venus Remedies and its competitors.
Is Venus Remedies' Total Equity too high?
Venus Remedies' current Total Equity is ₹6,638 Mil. Overall, Venus Remedies has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Venus Remedies' Total Equity compare to ZTS and UTHR?
Venus Remedies' Total Equity of ₹6,638 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Venus Remedies and its competitors. Venus Remedies's current Total Equity is ₹6,638 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Venus Remedies stock overvalued right now?
Based on GuruFocus' analysis, Venus Remedies (BOM:526953) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹468.24, compared to a current price of ₹1,703.85 — trading 263.9% above its estimated fair value. The current Total Equity is ₹6,638 Mil. Venus Remedies' overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Venus Remedies (BOM:526953), the current Total Equity is ₹6,638 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Venus Remedies (BOM:526953) Overvalued in 2026?

Based on GuruFocus' analysis, Venus Remedies stock appears to be overvalued. The current stock price of ₹1,703.85 is trading 263.9% above its estimated GF Value™ of ₹468.24. GuruFocus considers Venus Remedies to be Significantly Overvalued.

Key valuation signals for BOM:526953:

  • Total Equity: ₹6,638 Mil
  • GF Value™: ₹468.24 vs. price of ₹1,703.85 (263.9% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BOM:526953 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Venus Remedies Business Description

Other Exchanges VENUSREM:India
Address Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.
53GF Score

Get the complete analysis for BOM:526953

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,703.85
Price
₹468.24
GF Value